FGF4: Potential Cancer Treatments and Research Focus (G2249)

Target Name: FGF4

NCBI ID: G2249

FGF4: Potential Cancer Treatments and Research Focus

Heparin-binding growth factor 4 (FGF4) is a protein that is expressed in various tissues throughout the body, including the liver, pancreas, and skin. It plays a crucial role in cell growth, development, and repair. FGF4 has also been shown to be involved in the development and progression of various diseases, including cancer. As a result, FGF4 has become a focus of interest for researchers and pharmaceutical companies looking for new treatments.

FGF4 was first identified in the 1980s as a potential drug target for cancer. Since then, studies have shown that FGF4 is involved in the development and progression of many different types of cancer, including breast, ovarian, and prostate cancer. FGF4 has also been shown to be involved in the regulation of cell growth and differentiation, as well as in the development of blood vessels.

One of the key challenges in studying FGF4 is its complex structure. FGF4 is a transmembrane protein that is involved in multiple different signaling pathways. It consists of four distinct domains: an extracellular domain, a transmembrane domain, an intracellular domain, and a C-terminal domain. The extracellular domain is involved in cell adhesion and interaction, while the transmembrane domain is responsible for the protein's ability to interact with other molecules. The intracellular domain is involved in the regulation of protein function, and the C-terminal domain is involved in the protein's stability and interactions with other proteins.

FGF4 has been shown to play a role in many different signaling pathways that are involved in cancer development. For example, studies have shown that FGF4 can promote the growth and survival of cancer cells. It has also been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die when they are no longer needed. In addition, FGF4 has been shown to be involved in the regulation of cell angiogenesis, which is the process by which new blood vessels are formed.

FGF4 has also been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that FGF4 is involved in the development of breast cancer. It has also been shown to be involved in the development of skin cancer, as well as in the progression of ovarian cancer. In addition, FGF4 has been shown to be involved in the development of prostate cancer, which is the most common cancer in men.

FGF4 has also been shown to be involved in the regulation of pain perception and neurogenesis. For example, studies have shown that FGF4 is involved in the regulation of pain sensitivity, as well as in the development of neurogenic plasticity. In addition, FGF4 has been shown to be involved in the regulation of neurogenesis, which is the process by which new neurons are formed in the brain.

In conclusion, FGF4 is a protein that has been shown to be involved in many different signaling pathways that are involved in cancer development and progression. As a result, FGF4 has become a focus of interest for researchers and pharmaceutical companies looking for new treatments for cancer and other diseases. Further research is needed to fully understand the role of FGF4 in these processes, as well as to develop new treatments for these diseases.

Protein Name: Fibroblast Growth Factor 4

Functions: Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal limb and cardiac valve development during embryogenesis

More Common Targets